Blackstone Group LP agreed to buy BioMed Realty Trust Inc, a supplier of office space to healthcare companies, in a deal valued at $8 billion, adding to the private equity firm’s huge real estate portfolio.
BioMed’s shares were up 8.6 percent at $23.45 in premarket trading, just shy of the offer price of $23.75.
{iframe}http://www.reuters.com/article/2015/10/08/us-biomed-realty-m-a-blackstonerealty-idUSKCN0S215820151008{/iframe}